Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M99.7Revenue (TTM) $M2.0Net Margin (%)-1,911.6Altman Z-Score-60.5
Enterprise Value $M111EPS (TTM) $-1.7Operating Margin %-1,844.4Piotroski F-Score1
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,911.6Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-27.5Quick Ratio1.8Cash flow > EarningsN
Price/Sales45.55-y EBITDA Growth Rate %-6.0Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-129.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-353.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.3ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

SNSS is held by these investors:

SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MPM Oncology Impact Management10% Owner 2017-11-06Buy81,500$2.775.05view
Misfeldt DaytonDirector 2017-10-27Buy400,000$245.5view
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.87-24.81view
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.87-24.81view
Parker Geoffrey M.Director 2016-05-26Buy1,583$2.823.19view
Parker Geoffrey M.Director 2016-05-25Buy8,751$2.823.19view
Misfeldt DaytonDirector 2015-12-21Buy291,667$5.04-42.26view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy4,167$6.06-51.98view
Ketchum Steven BDirector 2015-07-24Sell1,060$20.76-85.98view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell1,060$20.76-85.98view

Press Releases about SNSS :

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Sunesis to Host Conference Call on November 2nd to Discuss Third Quarter 2017 Financial Results and Oct 27 2017 
Sunesis Announces Pricing of $20 Million Offering of Securities Oct 25 2017 
Sunesis Announces Proposed Public Offering of Common Stock, Preferred Stock and Warrants Oct 24 2017 
Sunesis to Present at Upcoming Investor Conferences Aug 31 2017 
Sunesis to Host Conference Call on July 27th to Discuss Second Quarter 2017 Financial Results and Re Jul 24 2017 
Sunesis Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Oral Non-Covale Jul 18 2017 
Sunesis Pharmaceuticals Announces Presentation of Updated Results from Washington University-Sponsor Jun 23 2017 
Lifshitz & Miller LLP Announces Investigation of Anadarko Petroleum Corporation, DryShips Inc., Immu May 15 2017 
Sunesis Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Highlights May 08 2017 
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sunesis Pharmaceuticals, Inc. for May 02 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat